U.S. Physical Therapy (NYSE:USPH) Stock Unloaded Rep. Josh Gottheimer

Representative Josh Gottheimer (D-New Jersey) recently sold shares of U.S. Physical Therapy, Inc. NYSE: USPH. In a filing disclosed on May 14th, the Representative disclosed that they had sold between $1,001 and $15,000 in U.S. Physical Therapy stock on April 17th. The trade occurred in the Representative's "MORGAN STANLEY - SELECT UMA ACCOUNT # 1" account.

Representative Josh Gottheimer also recently made the following trade(s):

• Purchased $1,001 - $15,000 in shares of RTX NYSE: RTX on 4/23/2025.
• Purchased $1,001 - $15,000 in shares of Cheniere Energy NYSE: LNG on 4/22/2025.
• Purchased $1,001 - $15,000 in shares of Techtronic Industries OTCMKTS: TTNDY on 4/21/2025.
• Purchased $1,001 - $15,000 in shares of Tri Pointe Homes NYSE: TPH on 4/21/2025.
• Purchased $1,001 - $15,000 in shares of Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk NYSE: TLK on 4/21/2025.
• Sold $1,001 - $15,000 in shares of KKR & Co. Inc. NYSE: KKR on 4/21/2025.
• Purchased $1,001 - $15,000 in shares of D.R. Horton NYSE: DHI on 4/21/2025.
• Purchased $1,001 - $15,000 in shares of Home Depot NYSE: HD on 4/21/2025.
• Sold $1,001 - $15,000 in shares of Hillman Solutions NASDAQ: HLMN on 4/17/2025.
• Sold $1,001 - $15,000 in shares of AbbVie NYSE: ABBV on 4/17/2025.

U.S. Physical Therapy Stock Up 1.3%

Shares of NYSE USPH opened at $78.23 on Friday. U.S. Physical Therapy, Inc. has a 12-month low of $62.77 and a 12-month high of $107.72. The company has a market capitalization of $1.19 billion, a PE ratio of 83.22, a price-to-earnings-growth ratio of 3.54 and a beta of 1.44. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.78. The firm's 50-day moving average is $71.84 and its two-hundred day moving average is $83.56.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported $0.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.46 by $0.02. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. The business had revenue of $183.79 million for the quarter, compared to the consensus estimate of $176.78 million. During the same quarter in the prior year, the firm posted $0.51 earnings per share. The company's quarterly revenue was up 18.0% compared to the same quarter last year. Equities analysts anticipate that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, June 13th. Shareholders of record on Friday, May 23rd will be given a dividend of $0.45 per share. The ex-dividend date of this dividend is Friday, May 23rd. This represents a $1.80 annualized dividend and a yield of 2.30%. U.S. Physical Therapy's payout ratio is currently 82.57%.

Insider Transactions at U.S. Physical Therapy

In other news, COO Graham D. Reeve sold 1,730 shares of the business's stock in a transaction on Friday, March 7th. The shares were sold at an average price of $82.11, for a total value of $142,050.30. Following the sale, the chief operating officer now owns 7,168 shares in the company, valued at approximately $588,564.48. The trade was a 19.44% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 2.00% of the stock is owned by corporate insiders.

Institutional Trading of U.S. Physical Therapy

Several institutional investors have recently made changes to their positions in USPH. CBIZ Investment Advisory Services LLC lifted its stake in U.S. Physical Therapy by 59.8% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company's stock valued at $29,000 after acquiring an additional 122 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. lifted its stake in U.S. Physical Therapy by 952.4% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 442 shares of the company's stock valued at $32,000 after acquiring an additional 400 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new stake in U.S. Physical Therapy in the fourth quarter valued at approximately $39,000. Venturi Wealth Management LLC lifted its stake in U.S. Physical Therapy by 3,200.0% in the fourth quarter. Venturi Wealth Management LLC now owns 726 shares of the company's stock valued at $64,000 after acquiring an additional 704 shares during the last quarter. Finally, Lazard Asset Management LLC acquired a new stake in shares of U.S. Physical Therapy in the fourth quarter worth $84,000.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on the stock. Barrington Research lowered their price target on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating for the company in a report on Friday, February 28th. JMP Securities reiterated a "market outperform" rating and set a $113.00 price objective on shares of U.S. Physical Therapy in a research note on Tuesday, April 22nd. JPMorgan Chase & Co. reduced their price objective on shares of U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating on the stock in a research note on Wednesday, March 19th. William Blair reiterated a "market perform" rating on shares of U.S. Physical Therapy in a research note on Thursday, February 27th. Finally, StockNews.com upgraded shares of U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research note on Thursday, May 8th. Two analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $109.00.

About Representative Gottheimer

Josh Gottheimer (Democratic Party) is a member of the U.S. House, representing New Jersey's 5th Congressional District. He assumed office on January 3, 2017. His current term ends on January 3, 2027. Gottheimer (Democratic Party) is running for re-election to the U.S. House to represent New Jersey's 5th Congressional District. He declared candidacy for the 2026 election. Gottheimer is also running for election for Governor of New Jersey. He declared candidacy for the Democratic primary scheduled on June 10, 2025. Gottheimer attended the University of Pennsylvania for his undergraduate degree. He became a Thouron Fellow at Oxford and attended Harvard Law School. Gottheimer worked as a speech writer under former President Bill Clinton (D), assisting with two State of the Union addresses, among other projects. Before running for Congress, he worked for Microsoft as a general manager for corporate strategy.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.